10x Genomics (TXG)
(Delayed Data from NSDQ)
$27.59 USD
+0.69 (2.57%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $27.92 +0.33 (1.20%) 7:58 PM ET
2-Buy of 5 2
D Value A Growth B Momentum B VGM
Detailed Estimates
EPS Estimates
Earnings Date | *AMC4/30/24 |
---|---|
Current Quarter | -0.46 |
EPS Last Quarter | -0.41 |
Last EPS Surprise | -13.89% |
ABR | 1.74 |
Earnings ESP
|
35.15% |
---|---|
Current Year | -1.47 |
Next Year | -0.78 |
EPS (TTM) | -1.89 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 142.04M | 155.55M | 677.59M | 796.49M |
# of Estimates | 6 | 5 | 6 | 6 |
High Estimate | 144.40M | 163.70M | 685.50M | 862.74M |
Low Estimate | 136.97M | 151.20M | 670.64M | 751.80M |
Year ago Sales | 134.29M | 146.82M | 618.73M | 677.59M |
Year over Year Growth Est. | 5.77% | 5.95% | 9.51% | 17.55% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.46 | -0.47 | -1.47 | -0.78 |
# of Estimates | 6 | 5 | 7 | 7 |
Most Recent Consensus | -0.48 | -0.55 | -1.74 | -1.18 |
High Estimate | -0.30 | -0.36 | -1.09 | -0.33 |
Low Estimate | -0.55 | -0.55 | -1.74 | -1.18 |
Year ago EPS | -0.44 | -0.53 | -1.66 | -1.47 |
Year over Year Growth Est. | -4.55% | 11.32% | 11.45% | 46.90% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 0 | 0 |
Up Last 30 Days | 1 | 1 | 1 | 1 |
Up Last 60 Days | 1 | 1 | 2 | 1 |
Down Last 7 Days | 0 | 0 | 0 | 0 |
Down Last 30 Days | 0 | 0 | 0 | 0 |
Down Last 60 Days | 0 | 0 | 0 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.46 | -0.47 | -1.47 | -0.78 |
7 Days Ago | -0.46 | -0.47 | -1.47 | -0.78 |
30 Days Ago | -0.46 | -0.47 | -1.47 | -0.79 |
60 Days Ago | -0.46 | -0.47 | -1.48 | -0.74 |
90 Days Ago | -0.49 | -0.45 | -1.55 | -0.36 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.30 | -0.36 | -1.09 | -0.52 |
Zacks Consensus Estimate | -0.46 | -0.47 | -1.47 | -0.78 |
Earnings ESP | 35.15% | 21.91% | 25.91% | 33.00% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.41 | -0.51 | -0.53 | -0.44 | NA |
Estimate | -0.36 | -0.45 | -0.39 | -0.38 | NA |
Difference | -0.05 | -0.06 | -0.14 | -0.06 | -0.08 |
Surprise | -13.89% | -13.33% | -35.90% | -15.79% | -19.73% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more